CD79A and COVID-19: Compared to the “prior COVID-19” subjects post-dose 1, S-binding Ab titres were lower in the “no prior COVID-19” group post-dose 2 (1.8- and fivefold, p < 0.001 for IgG and IgA, respectively, Fig. 4A,B).